Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents
PLOS ONE · 12.09.2024 · 19 (9) · e0306973
DOI: 10.1371/journal.pone.0306973 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 12.09.2024. Verfasst von Fatemeh Aghahosseini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Faculty of Science, Imam Khomeini International University, Qazvin, Iran. Hauptthemen laut MEDLINE: Molecular Docking Simulation, Hypoglycemic Agents, Pyridines, alpha-Amylases. Die Arbeit wurde bisher 24-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
There are numerous uses for the pharmacological effects of thiazolo-pyridine and its derivatives. The main objective of the study was to synthesis 10 novel derivatives of thiazolo[3,2- a ] pyridine-6,8-dicarbonitrile with a 22–78% yield, with a focus on their potential anti-diabetic properties. We investigated the interactions between these compounds and the enzyme α-amylase through an in silico study involving molecular docking. According to the docking analysis results, the resulting compounds had advantageous inhibitory properties. With a docking score of -7.43 kcal/mol against the target protein, compound 4e performed best. The stability root-mean-square deviation (RMSD) showed that the complex stabilizes after 25 ns and with minor perturbation at 80. The RMSF values of the ligand-protein complex indicate that the following residues have interacted with compound 4e during the MD simulation: Trp58, Trp59, Tyr62, Gln63, His101, Val107, lle148, Asn152, Leu162, Thr163, Gly164, Leu165, Asp197, Ala198, Asp 236, Leu237, His299, Asp300, and His305. Moreover, the pharmacokinetic and drug-like properties of the synthesized derivatives of 2-arylamino-dihydroindeno[1,2- b ] pyrrol-4(1 H )-one suggest that they have the potential to be effective inhibitors of α-amylase and should be considered for further research. Nevertheless, it is crucial to ascertain the in vivo and in vitro effectiveness of these compounds through biochemical and structural investigations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Faculty of Science, Imam Khomeini International University, Qazvin, Iran.
- Department of Chemistry, Faculty of Science, University of Guilan, Rasht, Iran.
ORCID-Profile: Mohammad Bayat, Davood Gheidari
Zitieren
APA
Aghahosseini, F., Bayat, M., Sadeghian, Z., Gheidari, D., & Safari, F. (2024). Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents. PLOS ONE, 19(9), e0306973. https://doi.org/10.1371/journal.pone.0306973
Vancouver
Aghahosseini F, Bayat M, Sadeghian Z, Gheidari D, Safari F. Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents. PLOS ONE. 2024;19(9):e0306973. doi:10.1371/journal.pone.0306973
BibTeX
@article{Aghahosseini2024,
author = {Aghahosseini, Fatemeh and Bayat, Mohammad and Sadeghian, Zahra and Gheidari, Davood and Safari, Fatemeh},
title = {Synthesis, molecular docking study, MD simulation, ADMET, and drug likeness of new thiazolo[3,2-a]pyridine-6,8-dicarbonitrile derivatives as potential anti-diabetic agents},
journal = {PLOS ONE},
year = {2024},
volume = {19},
number = {9},
pages = {e0306973},
doi = {10.1371/journal.pone.0306973}
}
EUVIMED